Total Payments
$14,455
2024 Payments
$1,829
Companies
27
Transactions
991
Payment Breakdown by Category
Food & Beverage$13,908 (96.2%)
Other$500.00 (3.5%)
Education$46.97 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $13,908 | 987 | 96.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $500.00 | 1 | 3.5% |
| Education | $46.97 | 3 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Sunovion Pharmaceuticals Inc. | $1,701 | 96 | $0 (2022) |
| Neos Therapeutics, LP | $1,694 | 171 | $0 (2024) |
| Supernus Pharmaceuticals, Inc. | $1,646 | 50 | $0 (2024) |
| Tris Pharma Inc | $1,247 | 71 | $0 (2024) |
| IRONSHORE PHARMACEUTICALS INC. | $1,145 | 65 | $0 (2024) |
| ABBVIE INC. | $959.49 | 62 | $0 (2024) |
| Alkermes, Inc. | $918.68 | 45 | $0 (2024) |
| Corium, LLC | $894.39 | 64 | $0 (2024) |
| Allergan, Inc. | $641.05 | 74 | $0 (2020) |
| Takeda Pharmaceuticals U.S.A., Inc. | $543.94 | 45 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,829 | 93 | Supernus Pharmaceuticals, Inc. ($497.16) |
| 2023 | $1,948 | 115 | Tris Pharma Inc ($389.77) |
| 2022 | $2,422 | 159 | Alkermes, Inc. ($393.04) |
| 2021 | $2,735 | 168 | Sunovion Pharmaceuticals Inc. ($612.87) |
| 2020 | $1,745 | 140 | Sunovion Pharmaceuticals Inc. ($324.41) |
| 2019 | $2,096 | 149 | Supernus Pharmaceuticals, Inc. ($608.65) |
| 2018 | $1,130 | 110 | Allergan Inc. ($214.64) |
| 2017 | $549.73 | 57 | PFIZER INC. ($189.98) |
All Payment Transactions
991 individual payment records from CMS Open Payments — Page 1 of 40
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Neos Therapeutics, LP | Cotempla XR-ODT (Drug) | Food and Beverage | Cash or cash equivalent | $13.29 | General |
| Category: ADHD | ||||||
| 12/04/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $21.64 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 12/02/2024 | Neos Therapeutics, LP | Adzenys XR-ODT (Drug) | Food and Beverage | Cash or cash equivalent | $13.32 | General |
| Category: ADHD | ||||||
| 11/21/2024 | Tris Pharma Inc | Dyanavel XR (Drug) | Food and Beverage | In-kind items and services | $23.10 | General |
| Category: ADHD | ||||||
| 11/18/2024 | Neos Therapeutics, LP | Adzenys XR-ODT (Drug) | Food and Beverage | Cash or cash equivalent | $11.42 | General |
| Category: ADHD | ||||||
| 11/18/2024 | Neos Therapeutics, LP | Adzenys XR-ODT (Drug) | Food and Beverage | Cash or cash equivalent | $1.43 | General |
| Category: ADHD | ||||||
| 11/13/2024 | IRONSHORE PHARMACEUTICALS INC. | JORNAY PM (Drug) | Food and Beverage | Cash or cash equivalent | $14.39 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 11/13/2024 | IRONSHORE PHARMACEUTICALS INC. | JORNAY PM (Drug) | Food and Beverage | Cash or cash equivalent | $5.13 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 11/04/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $23.64 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 11/04/2024 | Neos Therapeutics, LP | Adzenys XR-ODT (Drug) | Food and Beverage | Cash or cash equivalent | $12.41 | General |
| Category: ADHD | ||||||
| 11/04/2024 | Neos Therapeutics, LP | Adzenys XR-ODT (Drug) | Food and Beverage | Cash or cash equivalent | $0.86 | General |
| Category: ADHD | ||||||
| 10/24/2024 | Tris Pharma Inc | Dyanavel XR (Drug) | Food and Beverage | In-kind items and services | $23.34 | General |
| Category: ADHD | ||||||
| 10/21/2024 | Neos Therapeutics, LP | Cotempla XR-ODT (Drug) | Food and Beverage | Cash or cash equivalent | $13.21 | General |
| Category: ADHD | ||||||
| 10/17/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $16.75 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 10/15/2024 | IRONSHORE PHARMACEUTICALS INC. | JORNAY PM (Drug) | Food and Beverage | Cash or cash equivalent | $17.99 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 10/15/2024 | IRONSHORE PHARMACEUTICALS INC. | JORNAY PM (Drug) | Food and Beverage | Cash or cash equivalent | $3.77 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 10/10/2024 | Tris Pharma Inc | Dyanavel XR (Drug) | Food and Beverage | In-kind items and services | $12.80 | General |
| Category: ADHD | ||||||
| 10/10/2024 | Tris Pharma Inc | Dyanavel XR (Drug) | Food and Beverage | In-kind items and services | $3.03 | General |
| Category: ADHD | ||||||
| 10/08/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $29.76 | General |
| Category: NEUROSCIENCE | ||||||
| 10/07/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $23.64 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 10/07/2024 | Neos Therapeutics, LP | Cotempla XR-ODT (Drug) | Food and Beverage | Cash or cash equivalent | $13.00 | General |
| Category: ADHD | ||||||
| 10/03/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $14.56 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 09/23/2024 | Neos Therapeutics, LP | Cotempla XR-ODT (Drug) | Food and Beverage | Cash or cash equivalent | $12.46 | General |
| Category: ADHD | ||||||
| 09/19/2024 | IRONSHORE PHARMACEUTICALS INC. | JORNAY PM (Drug) | Food and Beverage | Cash or cash equivalent | $18.21 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 09/09/2024 | Neos Therapeutics, LP | Adzenys XR-ODT (Drug) | Food and Beverage | Cash or cash equivalent | $13.13 | General |
| Category: ADHD | ||||||
About Dr. John Steffek, MD
Dr. John Steffek, MD is a Child & Adolescent Psychiatry healthcare provider based in Spring, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/13/2007. The National Provider Identifier (NPI) number assigned to this provider is 1427181932.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Steffek, MD has received a total of $14,455 in payments from pharmaceutical and medical device companies, with $1,829 received in 2024. These payments were reported across 991 transactions from 27 companies. The most common payment nature is "Food and Beverage" ($13,908).
Ad
Practice Information
- Specialty Child & Adolescent Psychiatry
- Location Spring, TX
- Active Since 03/13/2007
- Last Updated 07/08/2007
- Taxonomy Code 2084P0804X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1427181932
Products in Payments
- LATUDA (Drug) $1,701
- VRAYLAR (Drug) $1,584
- Adzenys XR-ODT (Drug) $1,475
- JORNAY PM (Drug) $1,145
- Dyanavel XR (Drug) $934.34
- LYBALVI (Drug) $811.74
- VYVANSE (Drug) $707.32
- Azstarys (Drug) $648.12
- QELBREE (Drug) $540.67
- Qelbree (Drug) $497.16
- Equetro (Drug) $391.96
- ADHANSIA XR (Drug) $312.29
- RELEXXII (Drug) $251.22
- AZSTARYS (Drug) $246.27
- Cotempla XR-ODT (Drug) $210.38
- QUILLICHEW ER (Drug) $194.29
- REXULTI (Drug) $179.40
- Quillivant (Drug) $169.71
- Quillivant XR (Drug) $142.85
- INGREZZA (Drug) $139.06
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Child & Adolescent Psychiatry Doctors in Spring
Victor Oderinde, M.d, M.D
Child & Adolescent Psychiatry — Payments: $7,740
Child & Adolescent Psychiatry $7,740
Olayinka Ayeni, Md, MD
Child & Adolescent Psychiatry — Payments: $1,284
Child & Adolescent Psychiatry $1,284
Dr. Vishnu Challapalli, M.d, M.D
Child & Adolescent Psychiatry — Payments: $257.22
Child & Adolescent Psychiatry $257.22